Gastrointestinal stromal tumour - A paradigm shift in management of solid tumours

Journal of Association of Physicians of India

Volumn 51, Issue AUG, 2003, Pages 801-804

  Bapsy, P P ^a   Prabhash, K ^a   Babu, K G ^a   Girish, M H ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; ENZYME INHIBITOR; IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE; STEM CELL FACTOR RECEPTOR;

ADJUVANT THERAPY; ARTIFICIAL EMBOLISM; DRUG ANTAGONISM; GASTROINTESTINAL TUMOR; GENETIC MARKER; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; REVIEW;

ANTINEOPLASTIC AGENTS; EMBOLIZATION, THERAPEUTIC; ENZYME INHIBITORS; GASTROINTESTINAL NEOPLASMS; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; PIPERAZINES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RADIOTHERAPY, ADJUVANT;

EID: 1542679303     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Mazur MT, Clark HB. Gastric stromal tumours : Reappraisal of histogenesis. Am J Surg Pathol 1983;7:505-19.
2. Fletcher DM, Berman JJ, Corless C. Diagnosis of gastrointestinal stromal tumors : a consensus approach. Hum Pathol 2002;33:459-65.
3. Sircar K, Hewlett BR, Huizinga ZD, et al. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumours. Am J Surg Pathol 1999;23:377-89.
4. Heinrich MC, Rubin BP, Longley BJ, et al. Biology and genetic aspects of gastrointestinal stromal tumours: KIT activation and cytogenetic alterations. Hum Pathol 2002;33:484-95.
5. Lux ML, Rubin BP, Biase TL, et al. KIT extracellular and kinase domain mutation in gastrointestinal stromal tumours. Am J Pathol 2000;156:791-5.
6. Longlely BJ, Reguera MJ, Ma Y. Classes of c-KIT activating mutations: proposed mechanism of action and implications for disease classification and therapy. Leuk Res 2001;25:571-6.
7. Rifai W, Sarlomo-Rikala M, Andersson LC, et al. DNA sequence copy number changes in gastrointestinal stromal tumours: Tumours progression and prognostic significance. Cancer Res 2000;60:3899-903.
8. Hornick JL, Fletcher CDM. Immonohistochemical staining for KIT (CD117) in soft tissue sarcoma is very limited in distribution. Am J Clin Pathol 2002;117:188-93.
9. Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth muscle (stromal) tumours: Dependence on anatomic site. Am J Surg Pathol 1999;23:82-7.
10. Miettinen M, El-rifai W, Sobin LH, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumours : a review. Human Pathol 2002;33:478-83.
11. Derre J, Lagace R, Terrier P, et al. Consistent DNA losses on the short arm of chromosome 1 in a series of malignant gastrointestinal stromal tumours. Cancer Genet Cytogenet 2001;127:30-3.
12. Sakurai S, Fukayama M, Kalzaki Y, et al. Telomerase activity in gastrointestinal stromal tumours. Cancer 1998;83:2060-6.
13. DeMatteo RP, Lewis JL, Leung D, et al. Two hundred gastrointestinal stromal tumours: Recurrence patterns and prognostic factors for survival. Ann Surg 2000;23:51-7.
14. Dematteo P, Heinrich MC, El-rifai M, et al. Clinical management of gastrointestinal stromal tumours: before and after STI-571. Hum Pathol 2002;33:466-77.
15. Eilber FC, Rosen G, Forscher C, et al. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcoma. Ann Surg Oncol 1999;6:645-50.
16. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-7.
17. Blanke CD, Von Mehren M, Joensurr H, et al. Evaluation of the molecularly targeted therapy STI-571 in patients with unresectable or metastatic gastrointestinal stromal tumours expressing KIT. ASCO PROC 2001;20:2.
18. Van Oosterom AT, Judson I, Verweij J, et al. Safety and efficacy of imitanib (STI-571) in metastatic gastrointestinal stromal tumours: A phase I study. Lancet 2001;358:1421-3.
19. Sjoblom T, Shimizu A, O Brien KP, et al. Growth inhibition of dermatofibrosarcoma protuberans tumours by the plateletderived growth factor receptor antagonist STI-571 through induction of apoptosis. Cancer Res 2001;61:5778-83.